Skip to main
UNH

UnitedHealth Group (UNH) Stock Forecast & Price Target

UnitedHealth Group (UNH) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 21%
Buy 58%
Hold 13%
Sell 8%
Strong Sell 0%

Bulls say

UnitedHealth Group's outlook is positively influenced by anticipated earnings growth across its Optum segments, with projected increases of low to high single-digits and margin improvements ranging from 20 to 90 basis points. The overall earnings for UnitedHealth are expected to grow by 13% in 2026, primarily driven by enhanced profitability in the Medicare and commercial segments, as well as a significant expansion in operating margins. Furthermore, the company's vertical integration strategy, which combines its insurance and health services, positions UnitedHealth competitively within the healthcare sector, bolstering its revenue and margin potential across various business lines.

Bears say

The analysis of UnitedHealth Group's stock outlook reflects several critical challenges facing the organization, primarily related to declining membership across its key segments. The company anticipates a substantial reduction in its Medicare Advantage membership, projecting a drop of 1.3-1.4 million members, which exceeds previous estimates, primarily driven by increased plan shopping and general market reductions. Furthermore, the projected decline in Medicaid margins from 0.1% in 2025 to -1.8% in 2026, combined with continuous political pressures and insufficient rate adjustments relative to inflationary trends, exacerbates the financial strain on UnitedHealth Group’s operations.

UnitedHealth Group (UNH) has been analyzed by 24 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 58% recommend Buy, 13% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About UnitedHealth Group (UNH) Forecast

Analysts have given UnitedHealth Group (UNH) a Buy based on their latest research and market trends.

According to 24 analysts, UnitedHealth Group (UNH) has a Buy consensus rating as of Apr 16, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $363.17, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $363.17, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

UnitedHealth Group (UNH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.